Updated Jul 16, 2026
GEHCHAN NAJI is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Naji Gehchan is a prominent figure in the biotechnology sector, currently serving in a leadership role at Kyverna Therapeutics, Inc. He has a background in medicine and business, contributing to advancements in therapeutic solutions. His work focuses on innovative approaches to treating diseases, particularly in the field of immunology.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-17 | KYTX | Kyverna Therapeutics, Inc. | A — Grant or award | 18.0K | $0.00 |
Naji Gehchan is a prominent figure in the biotechnology sector, currently serving in a leadership role at Kyverna Therapeutics, Inc. He has a background in medicine and business, contributing to advancements in therapeutic solutions. His work focuses on innovative approaches to treating diseases, particularly in the field of immunology.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GEHCHAN NAJI profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.